Optiver Holding B.V.

Position in NVO — Novo Nordisk A S

CIK 1859606 AMSTERDAM, P7

Position in NVO

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,287,648

-$47,763,872 QoQ

Shares Held

47,719

-95.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#356

of 1,348 holders

Holding Since

Sep 2021

15 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Optiver Holding B.V. holds $26,373,774 across 11 Drug Manufacturers - General names. NVO ranks #3 (8.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	90,150	$17,094,243
2	SNY	Sanofi	115,761	$4,938,364
3	NVO	Novo Nordisk A S This page	47,719	$2,287,648
4	GSK	GSK plc	15,941	$835,627
5	AMGN	Amgen Inc	1,448	$524,349
6	GILD	Gilead Sciences, Inc.	1,941	$245,225
7	PFE	Pfizer Inc	7,242	$174,387
8	BMY	Bristol Myers Squibb Co	2,302	$132,641

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,287,648	47,719	-95.1%	Shares	Defined	2026-08-12
2025-12-31	$50,051,520	983,717	+105.4%	Shares	Defined	2026-02-17
2025-09-30	$26,579,044	478,988	+27.1%	Shares	Defined	2025-11-10
2025-06-30	$26,006,874	376,802	+292.2%	Shares	Defined	2025-08-14
2025-03-31	$6,671,448	96,075	-75.6%	Shares	Defined	2025-05-15
2024-12-31	$33,811,795	393,069	+3489.7%	Shares	Defined	2025-02-14
2024-09-30	$1,303,816	10,950	-94.5%	Shares	Defined	2024-11-14
2024-03-31	$25,479,696	198,440	+61.6%	Shares	Defined	2024-05-09
2023-12-31	$12,702,108	122,785	+1571.7%	Shares	Defined	2024-02-13
2023-03-31	$1,168,883	7,345	-93.0%	Shares	Defined	2023-05-11
2022-09-30	$10,485,360	105,243	+30.1%	Shares	Defined	2022-11-14
2022-06-30	$9,013,126	80,886	+18.5%	Shares	Defined	2022-08-10
2022-03-31	$7,580,828	68,265	+8.8%	Shares	Defined	2022-05-16
2021-12-31	$7,027,552	62,746	+0.7%	Shares	Defined	2022-02-14
2021-09-30	$5,982,479	62,311	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.